Skip to content

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
  • Home
  • About
    • NIH Collaboratory
      • Coordinating Center
      • NIH Collaboratory Trials
      • Core Working Groups
      • Steering Committee
      • Distributed Research Network
      • Our Impact
    • Living Textbook
      • Table of Contents
      • How to Use This Site
  • Resources
    • Data and Resource Sharing
    • Training Resources
    • Tools for Researchers
    • Publications
    • Knowledge Repository
  • Webinar
  • Podcast
  • News
    • News Feed
    • Calendar
    • Subscribe
return to home
Subscribe to Newsletter go to twitter feed go to linkedin go to blue sky feed
Search
NIH Collaboratory
Living Textbook of
Pragmatic Clinical Trials

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
home button

Rethinking Clinical Trials

A Living Textbook of Pragmatic Clinical Trials

  • Design
    • What is a Pragmatic Clinical Trial?
    • Decentralized Pragmatic Clinical Trials
    • Developing a Compelling Grant Application
    • Experimental Designs and Randomization Schemes
    • Endpoints and Outcomes
    • Analysis Plan
    • Using Electronic Health Record Data
    • Building Partnerships and Teams to Ensure a Successful Trial
    • Intervention Delivery and Complexity
    • Patient Engagement
  • Data, Tools & Conduct
    • Assessing Feasibility
    • Acquiring Real-World Data
    • Assessing Fitness-for-Use of Real-World Data
    • Study Startup
    • Participant Recruitment
    • Monitoring Intervention Fidelity and Adaptations
    • Patient-Reported Outcomes
    • Clinical Decision Support
    • Mobile Health
    • Electronic Health Records–Based Phenotyping
    • Navigating the Unknown
  • Dissemination & Implementation
    • Data Sharing and Embedded Research
    • Dissemination Approaches for Different Audiences
    • Implementation
    • End-of-Trial Decision-Making
  • Ethics & Regulatory
    • Privacy Considerations
    • Identifying Those Engaged in Research
    • Collateral Findings
    • Consent, Disclosure, and Non-Disclosure
    • Data and Safety Monitoring
    • Ethical Considerations of Data Sharing in Pragmatic Clinical Trials
    • Ethics for AI and ML
    • IRB Responsibilities and Procedures

Dissemination to Patients

CHAPTER SECTIONS

Dissemination Approaches for Different Audiences


Section 5

Dissemination to Patients

Expand Contributors

Hayden B. Bosworth, PhD
David Chambers, DPhil
Ellen Tambor, MA
Beverly B. Green, MD, MPH
Susan Huang, MD, MPH
Kevin P. Weinfurt, PhD
Doug Zatzick, MD

Contributing Editor
Damon M. Seils, MA

Dissemination Options for Trial Results

Lay audiences, including patients, caregivers, and others who are not experts in clinical research, often do not have access to clinical journals. Therefore, alternative dissemination media to scientific publications may be the most appropriate. Community-based research partners may already have communication channels open to patients and caregivers, and teaming with these partners from the beginning can help formulate the appropriate messages and the best means for disseminating results.

Key Point: When communicating with patients and research partners who are not routinely engaged in the clinical research enterprise, ensure that the information is accessible by disseminating through the following:

  • Patient advocacy groups
  • Government and study-specific websites
  • Newsletters
  • Emails
  • Social media
  • News media

Engagement Examples From PCORnet

A good example of a dissemination tactic aimed at patients and their caregivers comes from one of PCORnet’s Clinical Research Networks, PEDSnet, a network of children’s hospitals formed as a national evidence generation system to accelerate clinical research at lower cost. The PEDSnet website offers information about upcoming studies, opportunities to enroll in studies, summary results about the network’s impact, information about how to get involved in the network’s family and youth councils and become a patient and family advisor.

Another PCORnet Clinical Research Network, the PaTH Network, launched an innovative resource known as the Story Booth project. The project is an audio archive of patients living with an illness or experiencing a health challenge, with the goal of educating health researchers about patients’ and caregivers’ priorities and engaging patients and caregivers as research partners. The Story Booth website allows users to search for audio stories by the type of storyteller and by health experience.

Plain Language and Lay Summaries

When disseminating information to patients and other lay audiences, the use of plain language that is clear, professional, and easy to understand is recommended. The NIH created a 1-page guide to clarify the difference between observational studies and randomized clinical trials, but the guide does not communicate information about the unique aspects of pragmatic clinical trials, such as what is meant by embedded research, cluster randomized trials, or stepped-wedge designs. Communications aimed at a broader audience, such as the public, should explicitly define these terms. For communicating the results, the NIH also created a Checklist for Communicating Science and Health Research to the Public.

In brief, NIH recommendations for clinical trials are:

  • Describe the clinical trial phase
  • Give a breakdown of the study participants’ demographics
  • Identify and explain the limitations of the study’s endpoint
    • Surrogate endpoints
    • Composite endpoints
  • Check the study’s sample size and address potential limitations
  • Clearly explain risk
    • Absolute risk
    • Relative risk/risk ratio
  • Discuss both the benefits and drawbacks

Communicating the results of pragmatic (or embedded) research should include:

  • The importance of the project and the gaps in knowledge the project is intended to address
  • Rationale for a pragmatic approach, including an explanation of the study’s design
  • Decisions the trial is intended to inform for patients, caregivers, and clinicians
  • Use of data from the EHR and related privacy protections
  • Generalizability of results

Lay summaries of study results can be an important strategy for disseminating results to research participants and the general public. For example, the Pediatric Trials Network (PTN) maintains an archive of “results at-a-glance” to share the results of the network’s clinical trials in plain language.


Lay summary of a PTN trial of lorazepam in children with status epilepticus

Lay summaries are also becoming an important and increasingly common approach by biomedical journals for improving the accessibility of results reporting. Many journals now require authors to prepare lay summaries to accompany their research articles. Goldstein and Krukowski (2023) described best practices for developing lay summaries.

Storytelling

Another dissemination tactic is to use storytelling methods. Presenting factual data and personal stories has been found to help people use the information and results from studies. Brason Lee commented in the American Journal of Public Health:

“It is about writing reports in a way that inspires readers to care enough to move forward. It is about showing readers rather than telling readers what it is like to be in a given situation….one of the greatest challenges in disseminating research for public policy use may ultimately rest in how the story is packaged for presentation.” (Lee 2015)

The communications departments in universities, research institutions, and healthcare systems can provide invaluable help in making a message clear and compelling.

The Patient-Centered Outcomes Research Institute (PCORI) offers a collection of stories about the impact of PCORI’s research on patients, researchers, and communities.

Resources for Patients

Several patient-oriented educational resources from government agencies and healthcare organizations are available for patients who want to learn more about clinical research. They include Basic Research Concepts from the US Department of Health and Human Services, Patient Resources from ClinicalTrials.gov, and the NIH Clinical Research Trials and Youwebsite.

Previous Section Next Section

SECTIONS

CHAPTER SECTIONS

sections

  1. Introduction
  2. Reporting to the Scientific Community
  3. Case Study: Journal Reviews of NIH Collaboratory Trials
  4. ClinicalTrials.gov
  5. Dissemination to Patients
  6. Dissemination to Clinicians and Health Systems
  7. Dissemination Case Studies
  8. Additional Resources

Resources

Returning Individual Research Results to Participants: Guidance for a New Research Paradigm
NIH Pragmatic Trials Collaboratory Rethinking Clinical Trials Grand Rounds; September 21, 2018

Returning Individual Research Results to Participants: Guidance for a New Research Paradigm
NIH Pragmatic Trials Collaboratory Rethinking Clinical Trials Podcast interview with Jeffrey Botkin and Consuelo Wilkins

Making Measurements Meaningful
NIH Pragmatic Trials Collaboratory Rethinking Clinical Trials Grand Rounds; October 18, 2018

Moving Beyond Return of Research Results to Return of Value
NIH Pragmatic Trials Collaboratory Rethinking Clinical Trials Grand Rounds; June 28, 2019

The Democratization of Medicine: Open Access, Social Media, AI, Apps, and Empowering the Patient as the Future of Clinical Research
NIH Pragmatic Trials Collaboratory Rethinking Clinical Trials Grand Rounds; August 7, 2020

A Cross-Sectional Study of GPT-4–Based Plain Language Translation of Clinical Notes to Improve Patient Comprehension of Disease Course and Management
NIH Pragmatic Trials Collaboratory Rethinking Clinical Trials Grand Rounds; March 28, 2025

REFERENCES

back to top

Botkin JR, Wilkins C. 2018. Returning Individual Research Results to Participants: Guidance for a New Research Paradigm. NIH Collaboratory Grand Rounds. https://rethinkingclinicaltrials.org/news/september-21-2018-returning-individual-research-results-to-participants-guidance-for-a-new-research-paradigm-jeffrey-botkin-md-mph-consuelo-wilkins-md-msci/. Accessed April 15, 2024.

Goldstein CM, Krukowski RA. 2023. The importance of lay summaries for improving science communication. Ann Behav Med. 57(7):509-510. doi: 10.1093/abm/kaad027. PMID: 37379509.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on the Return of Individual-Specific Research Results Generated in Research Laboratories. 2018. Returning Individual Research Results to Participants: Guidance for a New Research Paradigm. Downey AS, Busta ER, Mancher M, Botkin JR, editors. Washington (DC): National Academies Press. PMID: 30001048.

back to top

Lee B. 2015. Storytelling to enhance the value of research. Am J Public Health. 105(4):e1. doi: 10.2105/AJPH.2014.302548. PMID: 25713935.

Wong CA, Hernandez AF, Califf RM. 2018. Return of research results to study participants: uncharted and untested. JAMA. 320(5):435-436. doi: 10.1001/jama.2018.7898. PMID: 29931289.

ACKNOWLEDGMENTS

back to top

Karen Staman, Gina Uhlenbrauck, and Liz Wing of the NIH Pragmatic Trials Collaboratory Coordinating Center served as contributing editors for previous versions of this chapter.


Version History

Published November 24, 2025.

current section :

Dissemination to Patients

  1. Introduction
  2. Reporting to the Scientific Community
  3. Case Study: Journal Reviews of NIH Collaboratory Trials
  4. ClinicalTrials.gov
  5. Dissemination to Patients
  6. Dissemination to Clinicians and Health Systems
  7. Dissemination Case Studies
  8. Additional Resources

Citation:

Bosworth HB, Chambers D, Tambor E, Green BB, Huang S, Weinfurt KP, Zatzick D. Dissemination Approaches for Different Audiences: Dissemination to Patients. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Pragmatic Trials Collaboratory. Available at: https://rethinkingclinicaltrials.org/chapters/dissemination/dissemination-approaches-for-different-audiences/dissemination-to-patients/. Updated December 11, 2025. DOI: 10.28929/294.

Footer Menu

  • How to Use This Site
  • About NIH Collaboratory
  • Enrollment Reporting
  • Grand Rounds
  • Funding Statement
Link to Twitter Link to LinkedIn Link to Blue Sky Link to NIH Collaboratory email

Reference in this Web site to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the U.S. Government or National Institutes of Health (NIH). NIH is not responsible for the contents of any “off-site” Web page referenced from this server.

Log in
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly. Site Map